Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as clofarabine and daunorubicin, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Giving clofarabine together with daunorubicin may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving clofarabine together with
daunorubicin works in treating older patients with newly diagnosed acute myeloid leukemia.